Expleo Life Sciences Belgium (SA)

Active
VAT

BE 0890.368.245

Commercial name

Assystem Care Belgium

Address
Route de Lennik 451
1070 Anderlecht
Established
15-06-2007
Principal activity
Engineering and technical consultancy activities, except surveying activities

Crisis resilience of Expleo Life Sciences Belgium

Which companies are best armed against current economic trends and the energy crisis?

Read more

Financial data of Expleo Life Sciences Belgium

2023 Financial statements 2022 Financial statements 2021 Financial statements 2020 Financial statements
Turnover -
-
-
-
€5,051,516
-30%
€7,238,127
Profit/Loss -€230,409
< -1.000%
-€11,887
91%
-€138,520
13%
-€159,999
Equity €609,184
-27%
€839,593
-1%
€851,480
> 1.000%
€66,981
Gross margin €2,927,851
4%
€2,821,658
-7%
€3,034,397
-29%
€4,250,542
Employees 38,9 FTE
-2%
39,8 FTE
-17%
47,9 FTE
-27%
65,3 FTE

Frequently asked questions

What is the VAT number of Expleo Life Sciences Belgium?
The VAT number of Expleo Life Sciences Belgium is BE0890368245.
When was Expleo Life Sciences Belgium founded?
Expleo Life Sciences Belgium was founded on 15-06-2007.
What is the address of Expleo Life Sciences Belgium?
The current registered office of Expleo Life Sciences Belgium is located at Route de Lennik 451, 1070 Anderlecht.
When was the last time Expleo Life Sciences Belgium filed their annual financial statements?
The most recent financial statements of Expleo Life Sciences Belgium were filed on 17-04-2024. You can view them here.
How many employees does Expleo Life Sciences Belgium have?
There are 38,9 FTEs working at Expleo Life Sciences Belgium according to the staff figures in the most recent financial statements.
What is the annual turnover of Expleo Life Sciences Belgium?
At the time of its most recent financial statements, Expleo Life Sciences Belgium did not publish any turnover figures. Expleo Life Sciences Belgium reported a gross margin of €2,927,850.50.
Address

  You have disabled Javascript on your computer. To use this website, please enable Javascript first.


More details